Growth Metrics

Evaxion A (EVAX) Current Leases (2019 - 2025)

Evaxion A posted quarterly Current Leases of $360000.0 for Q4 2025, up 14.65% year-on-year from $314000.0 in Q4 2024, and up 1.12% on a QoQ basis from $356000.0 in Q2 2025.

Evaxion A (EVAX) has 7 years of Current Leases data on file, last reported at $360000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 14.65% year-over-year to $360000.0; the trailing twelve-month figure through Dec 2025 stood at $360000.0 (up 14.65% YoY), and the FY2025 full-year result was $360000.0, up 14.65% from the prior year.
  • Current Leases for Q4 2025 stood at $360000.0, up from $356000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $2.3 million in Q3 2021 and bottomed at $292000.0 in Q2 2022.
  • The 5-year median for Current Leases is $319000.0 (2024), against an average of $579000.0.
  • The widest annual swing landed in 2021, when Current Leases jumped 1470.0%; it then slumped 70.47% in 2022.
  • A 5-year view of Current Leases shows it stood at $314000.0 in 2021, then dropped by 3.5% to $303000.0 in 2022, then grew by 7.59% to $326000.0 in 2023, then fell by 3.68% to $314000.0 in 2024, then grew by 14.65% to $360000.0 in 2025.
  • The last three Current Leases figures came in at $360000.0 (Q4 2025), $356000.0 (Q2 2025), and $314000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn - 16.61 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 360,000.00
Jun 30, 2025 356,000.00
Dec 31, 2024 314,000.00
Jun 30, 2024 319,000.00
Dec 31, 2023 326,000.00
Jun 30, 2023 318,000.00
Dec 31, 2022 303,000.00
Jun 30, 2022 292,000.00
Mar 31, 2022 311,000.00
Dec 31, 2021 314,000.00
Sep 30, 2021 2.29 Mn
Jun 30, 2021 974,000.00
Mar 31, 2021 1.05 Mn
Dec 31, 2020 20,000.00
Dec 31, 2019 36,000.00